NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
RecruitingOBSERVATIONAL
Enrollment
180
Participants
Timeline
Start Date
February 1, 2023
Primary Completion Date
June 30, 2024
Study Completion Date
February 1, 2026
Conditions
Progressive Supranuclear PalsyMultiple System AtrophyParkinson's Disease
Trial Locations (1)
350000
RECRUITING
Fujian Medical University Union Hospital, Fuzhou
All Listed Sponsors
lead
Fujian Medical University Union Hospital
OTHER
NCT06490926 - NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome | Biotech Hunter | Biotech Hunter